The market rally continued. Finishing strong Friday due to a potential COVID-19 treatment. The Dow, S&P, and Nasdaq indexes all finished up last week. Dow up 2.2%, S&P 3.0%, and Nasdaq 6.1%. Not all was good as many banks reported earnings last week. The large banks are preparing for potential consumer and corporate loan defaults. Unemployment increases continue. In the last four weeks, 22 million Americans have filed for unemployment. This volume erases ten years of job growth. Retail Sales dropped in March and Industrial Production fell to the lowest level since 1946.
So why did the markets finish higher? Good question. The markets response was focused on two things. First, the potential vaccine treatment. If this treatment works or has a strong recovery rate, this is great news for the current time and the future. The markets want to be reassured if the virus returns there is a defense in place. Second, President Trump announced a plan to reopen states. Going back to “normal” is good for small business, consumers, and income earners. It is clear “life after virus” will be different, igniting the economy is certainly a positive for financial markets.
The Week Ahead
COVID-19 hospitalizations are declining in hotspot areas. Government officials are working on plans to gradually reopen their states. On Thursday, another round of unemployment claims is expected. Friday’s durable goods order report will shed light on business spending amid the health crisis.
Corporate earnings season continues. The focus of these calls remain to be the gauge of how negatively affected consumption and credit have been for both consumers and businesses. As well as, the prospects of doing business during the next few quarters. And lastly, for firms not on solid footing, investors will look to their liquidity as key indicator of strength going forward.
Year-to-date index performance; Dow down 15.0%, S&P down 11.0%, and Nasdaq up 3.6%. As the post image says, “Together We Do It” – Have a safe week!
This website is for informational purposes only and is not intended to be specific advice or recommendations. For specific advice or recommendations you would need to meet directly with one of our advisers.